Otago's CRISPR method mutates phage genes across the genome to find the essential ones

Phages are viruses that infect bacteria, and their ability to destroy bacterial cells is what makes them candidates against antimicrobial resistance and a substitute for agrochemicals ^[2]. The bottleneck has been the genes: many encode functions no one has identified, which makes the viruses hard to predict or modify ^[3]. Peter Fineran, a senior author, put the state of the field plainly. He said our knowledge of phages is probably like the understanding of antibiotics back in the 1950s, with many phage genes still in the area of microbial dark matter, encoding functions we do not understand, and that this limits the ability to use phages in health care and biotechnology ^[4].

The Otago method attacks that with mutation at scale ^[1]. It borrows transposon insertion sequencing, in which a mobile piece of DNA jumps into a gene and breaks it ^[5]. To tell the mutants apart, the transposon also carries an anti-CRISPR gene, and a CRISPR-anti-CRISPR selection recovers the phages that took it up ^[6][7]. Those survivors show which genes a phage can lose and which it cannot, and the paper reports the method working across diverse phages ^[7][8].

The engineering result comes from a small change in how the transposon is used. Because it can carry cargo, it does not have to stop at breaking a gene. The team loaded it with extra sequence and inserted a fluorescent marker into phage genomes ^[9]. "Once we had that established, we thought we could expand the technique and also use it to add genes directly into the phage genomes," co-lead author Manuela Fuchs said ^[10]. The marker is a demonstration; the use they name is adding genes that let a phage overcome the systems bacteria use to defend themselves ^[9].

Leah Smith, a senior author, described the appeal as the method itself. "This is a systematic, broadly applicable and cost-effective way to not only investigate gene function, but also rapidly engineer phage genomes," she said ^[11]. She pointed to biofilms, the bacterial layers behind stubborn infections on prosthetic implants and medical devices, as a target ^[12]. "With this new technique, we could quickly equip phages with more tools to counter some bacterial defenses so that they can be harnessed to kill pathogens more easily," Smith said ^[13].

The work does not show that any of this treats an infection. The fluorescent marker proves cargo can be inserted, and the anti-defense genes are proposed, not built ^[9]. The researchers said engineered phages would still need further testing to establish safety and effectiveness for specific uses ^[14]. A genome-wide way to knock genes out lets a lab test a phage gene of unknown function ^[1][5].